70
Participants
Start Date
October 1, 2019
Primary Completion Date
February 14, 2023
Study Completion Date
June 17, 2024
PTG-300
Active
Placebo
Placebo
Mount Sinai, New York
New York Presbyterian Hospital - Weill Cornell Medical Center, New York
Center for Cancer and Blood Disorders, Bethesda
Moffitt Cancer Center, Tampa
Cleveland Clinic - Taussig Cancer Center, Cleveland
University of Michigan, Ann Arbor
Karmanos Cancer Center, Detroit
University of Kansas, Westwood
Pontchartrain Cancer Care, Covington
Mary Crowley Cancer Research Center, Dallas
The University of Texas MD Anderson Cancer Center, Houston
Mayo Clinic - Mayo Clinic Hospital, Phoenix
Stanford University, Palo Alto
Marin Cancer Care, Greenbrae
All India Institute of Medical Sciences, Rishikesh
Sahyadri Super Specialty Hospital, Pune
Protagonist Therapeutics, Inc.
INDUSTRY